share_log

Earnings Miss: Shandong Hualu-Hengsheng Chemical Co., Ltd. Missed EPS By 43% And Analysts Are Revising Their Forecasts

Earnings Miss: Shandong Hualu-Hengsheng Chemical Co., Ltd. Missed EPS By 43% And Analysts Are Revising Their Forecasts

盈利不及预期:华鲁恒升化工股份有限公司每股收益低于43%,分析师正在调整他们的预测
Simply Wall St ·  11/01 18:21

Last week saw the newest third-quarter earnings release from Shandong Hualu-Hengsheng Chemical Co., Ltd. (SHSE:600426), an important milestone in the company's journey to build a stronger business. It looks like a pretty bad result, all things considered. Although revenues of CN¥8.2b were in line with analyst predictions, statutory earnings fell badly short, missing estimates by 43% to hit CN¥0.39 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

上周,山东华鲁恒升化工有限公司(SHSE: 600426)发布了最新的第三季度财报,这是该公司建立更强大业务过程中的一个重要里程碑。考虑到所有因素,这看起来是一个非常糟糕的结果。尽管82元人民币的收入与分析师的预测一致,但法定收益严重不及预期,比预期低43%,达到每股0.39元人民币。根据结果,分析师更新了他们的盈利模式,很高兴知道他们是否认为公司的前景发生了巨大变化,或者业务是否照旧。考虑到这一点,我们收集了最新的法定预测,以了解分析师对明年的预期。

big
SHSE:600426 Earnings and Revenue Growth November 1st 2024
SHSE: 600426 2024 年 11 月 1 日收益和收入增长

After the latest results, the twelve analysts covering Shandong Hualu-Hengsheng Chemical are now predicting revenues of CN¥37.5b in 2025. If met, this would reflect a decent 13% improvement in revenue compared to the last 12 months. Per-share earnings are expected to soar 46% to CN¥2.54. In the lead-up to this report, the analysts had been modelling revenues of CN¥37.6b and earnings per share (EPS) of CN¥2.59 in 2025. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

最新业绩公布后,涵盖山东华鲁恒盛化工的十二位分析师现在预测2025年的收入为375元人民币。如果得到满足,这将反映出收入与过去12个月相比增长了13%的可观增长。每股收益预计将飙升46%,至2.54元人民币。在本报告发布之前,分析师一直在模拟2025年的收入为376元人民币,每股收益(EPS)为2.59元人民币。因此,很明显,尽管分析师已经更新了估计,但在最新业绩公布后,对该业务的预期没有重大变化。

The analysts reconfirmed their price target of CN¥31.82, showing that the business is executing well and in line with expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Shandong Hualu-Hengsheng Chemical, with the most bullish analyst valuing it at CN¥36.89 and the most bearish at CN¥27.69 per share. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Shandong Hualu-Hengsheng Chemical is an easy business to forecast or the the analysts are all using similar assumptions.

分析师再次确认了31.82元人民币的目标股价,这表明该业务表现良好,符合预期。但是,固定单一价格目标可能是不明智的,因为共识目标实际上是分析师目标股价的平均值。因此,一些投资者喜欢查看估计范围,看看对公司的估值是否有任何分歧。对山东华鲁恒升化工的看法有所不同,最看涨的分析师认为其估值为36.89元人民币,最看跌的为每股27.69元人民币。即便如此,在估值分组相对接近的情况下,分析师似乎对自己的估值相当有信心,这表明山东华鲁恒盛化工是一项易于预测的业务,或者分析师都使用了类似的假设。

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that Shandong Hualu-Hengsheng Chemical's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 11% growth on an annualised basis. This is compared to a historical growth rate of 19% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 16% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Shandong Hualu-Hengsheng Chemical.

现在从大局来看,我们理解这些预测的方法之一是看看它们与过去的表现和行业增长估计相比如何。很明显,预计山东华鲁恒升化工的收入增长将大幅放缓,预计到2025年底的收入按年计算将增长11%。相比之下,过去五年的历史增长率为19%。相比之下,该行业的其他公司(根据分析师的预测),后者的总体收入预计每年将增长16%。因此,很明显,尽管收入增长预计将放缓,但整个行业的增长速度预计也将超过山东华鲁恒升化学。

The Bottom Line

底线

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Shandong Hualu-Hengsheng Chemical's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

要了解的最重要的一点是,市场情绪没有重大变化,分析师再次确认该业务的表现符合他们先前的每股收益预期。幸运的是,分析师还重申了他们的收入预期,表明收入符合预期。尽管我们的数据确实表明,山东华鲁恒升化工的收入预计将低于整个行业。共识目标股价没有实际变化,这表明该业务的内在价值与最新估计相比没有发生任何重大变化。

With that in mind, we wouldn't be too quick to come to a conclusion on Shandong Hualu-Hengsheng Chemical. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Shandong Hualu-Hengsheng Chemical going out to 2026, and you can see them free on our platform here..

考虑到这一点,我们不会很快就山东华鲁恒升化工得出结论。长期盈利能力比明年的利润重要得多。在Simply Wall St,我们有分析师对山东华鲁恒盛化工到2026年的全方位估计,你可以在我们的平台上免费查看。

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Shandong Hualu-Hengsheng Chemical , and understanding this should be part of your investment process.

尽管如此,仍然有必要考虑永远存在的投资风险阴影。我们已经向山东华鲁恒升化工确定了一个警告信号,了解这应该是您投资过程的一部分。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发